Search Within

Ying Zhang Mazzu

Formats
  1. Meeting Abstract (19)
  2. Journal Article (15)
Groups
  1. Sloan Kettering Institute Postdocs (34)
  2. Department of Medicine (29)
  3. Genitourinary Oncology Service (29)
  4. Solid Tumor Oncology Division (29)
  5. GSK Faculty (9)
  6. Human Oncology and Pathogenesis Program (5)

More Groups

People
  1. Philip Kantoff (29)
  2. Goutam Chakraborty (27)
  3. Yuki Yoshikawa (23)
  4. Subhiksha Nandakumar (21)
  5. Lina Jehane (14)
  6. Mohammad Atiq (14)

More People

Years
  1. 2022 (4)
  2. 2021 (4)
  3. 2020 (7)
  4. 2019 (10)
  5. 2018 (6)
  6. 2017 (1)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Cancer Research (9)
  3. Clinical Cancer Research (4)
  4. Molecular Oncology (4)
  5. American Journal of Chinese Medicine (1)
  6. Annals of Surgical Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (14)
  2. American Society of Clinical Oncology (10)
  3. FEBS Press (4)
  4. Nature Publishing Group (2)
  5. American Society for Clinical Investigation (1)
  6. Elsevier Inc. (1)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Increased MYBL2 expression in aggressive hormone-sensitive prostate cancer
    Journal Article

    Yoshikawa, Y.; Stopsack, K. H.; Wang, X. V.; Chen, Y. H.; Mazzu, Y. Z.; Burton, F.; Chakraborty, G.; Rajanala, S. H.; Hirani, R.; Nandakumar, S.; more...
    Molecular Oncology (2022)

    Fulltext@MSK | Save
  • The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer
    Journal Article

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Nguyen, B.; Stopsack, K. H.; Kreitzer, C.; Rajanala, S. H.; Ghale, R.; Mazzu, Y. Z.; Pillarsetty, N. V. K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity
    Journal Article

    Mazzu, Y. Z.; Liao, Y.; Nandakumar, S.; Sjöström, M.; Jehane, L. E.; Ghale, R.; Govindarajan, B.; Gerke, T. A.; Lee, G. S. M.; Luo, J. H.; more...
    Molecular Oncology (2022)

    Fulltext@MSK | Save
  • Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer
    Journal Article

    Mazzu, Y. Z.; Liao, Y. R.; Nandakumar, S.; Jehane, L. E.; Koche, R. P.; Rajanala, S. H.; Li, R.; Zhao, H. Y.; Gerke, T. A.; Chakraborty, G.; more...
    Oncogene (2022)

    Fulltext@MSK | Save
  • Bcl-2 inhibitor enhances anti-androgen therapy induced regression of castration sensitive prostate cancer
    Meeting Abstract

    Hirani, R.; Nandakumar, S.; Kalidindi, T.; Fidele, D.; Rajanala, H.; Mazzu, Y.; Yoshikawa, Y.; Jehane, L.; Lee, G. S. M.; de Stanchina, E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Identification and characterization of the PIK3R1-mutant subtype in PI3K-addicted prostate cancer
    Meeting Abstract

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Rajanala, S. H.; Nguyen, B.; Ghale, R.; Mazzu, Y. Z.; Jehane, L. E.; Lee, G. S. M.; Mucci, L. A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Significance of targeting the antiapoptotic pathway in castration-sensitive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Hirani, R.; Nandakumar, S.; Kalidindi, T. M.; Fidele, D.; Rajanala, S. H.; Mazzu, Y. Z.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Attenuation of SRC kinase activity augments PARP inhibitor-mediated synthetic lethality in BRCA2-altered prostate tumors
    Journal Article

    Chakraborty, G.; Khan Patail, N.; Hirani, R.; Nandakumar, S.; Mazzu, Y. Z.; Yoshikawa, Y.; Atiq, M.; Jehane, L. E.; Stopsack, K. H.; Lee, G. S. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Combined inhibition of androgen signaling and apoptosis pathways in hormone sensitive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Hirani, R.; Jehane, L. E.; Mazzu, Y. Z.; Yoshikawa, Y.; Rajanala, S. H.; Lee, G. S. M.; Kantoff, P. W.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
    Journal Article

    Mazzu, Y. Z.; Armenia, J.; Nandakumar, S.; Chakraborty, G.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; Atiq, M.; Khan, N.; Schultz, N.; more...
    Molecular Oncology (2020)

    Fulltext@MSK | Save